For Boston Scientific, a ‘most difficult year’
1 min readPostponed elective surgeries cost the medical device maker half its business, and George Floyd’s death in Minneapolis hit close to home Mike Mahoney is Boston Scientific’s chief executive. When Mike Mahoney first heard about the new coronavirus, in January, it struck him as a scientific curiosity confined to China. […]
Click here to view original web page at www.bostonglobe.com